HomeCompareUMPSX vs JNJ

UMPSX vs JNJ: Dividend Comparison 2026

UMPSX yields 0.14% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $160.00 in total portfolio value· pulled ahead in Year 9
10 years
UMPSX
UMPSX
● Live price
0.14%
Share price
$54.10
Annual div
$0.07
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$13.87
Full UMPSX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — UMPSX vs JNJ

📍 JNJ pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUMPSXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UMPSX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UMPSX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UMPSX
Annual income on $10K today (after 15% tax)
$11.68/yr
After 10yr DRIP, annual income (after tax)
$11.79/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $691.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UMPSX + JNJ for your $10,000?

UMPSX: 50%JNJ: 50%
100% JNJ50/50100% UMPSX
Portfolio after 10yr
$19.9K
Annual income
$420.82/yr
Blended yield
2.11%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

UMPSX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UMPSX buys
0
JNJ buys
0
No recent congressional trades found for UMPSX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUMPSXJNJ
Forward yield0.14%3.36%
Annual dividend / share$0.07$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$19.9K$20.0K
Annual income after 10y$13.87$827.78
Total dividends collected$138.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: UMPSX vs JNJ ($10,000, DRIP)

YearUMPSX PortfolioUMPSX Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,714$13.75$10,676$355.77+$38.00UMPSX
2$11,477$13.76$11,407$389.39+$70.00UMPSX
3$12,295$13.78$12,198$426.53+$97.00UMPSX
4$13,169$13.80$13,056$467.62+$113.00UMPSX
5$14,105$13.81$13,987$513.12+$118.00UMPSX
6$15,106$13.82$14,998$563.56+$108.00UMPSX
7$16,177$13.84$16,098$619.52+$79.00UMPSX
8$17,323$13.85$17,295$681.69+$28.00UMPSX
9← crossover$18,550$13.86$18,599$750.82$49.00JNJ
10$19,862$13.87$20,022$827.78$160.00JNJ

UMPSX vs JNJ: Complete Analysis 2026

UMPSXStock

The fund invests in financial instruments that ProFund Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. It is a float-adjusted, market capitalization-weighted index of 400 U.S. operating companies and real estate investment trusts selected through a process that factors in criteria such as liquidity, price, market capitalization, financial viability and public float. The fund is non-diversified.

Full UMPSX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this UMPSX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UMPSX vs SCHDUMPSX vs JEPIUMPSX vs OUMPSX vs KOUMPSX vs MAINUMPSX vs ABBVUMPSX vs MRKUMPSX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.